$NBIS

Why is Nebius stock rallying today?

Nebius Group NV shares rose about 5.4% to $194.06 after Goldman Sachs issued a bullish pre-earnings note ahead of Q2 2026 results, citing strong AI infrastructure demand, sold-out Q1 capacity, and an asset-light model. CoreWeave is also set to report. DA Davidson cut its target to $175 from $250. Nebius Q1 revenue rose 684% YoY; FY guidance is $3.0B to $3.4B.

Original reporting
Published Aug 11, 2026, 1:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 2:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$NBIS
Bullish
medium confidence
Mentioned
$NBIS
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$NBISBullishMed
01

Why it matters

For traders, the key decision point is the upcoming Q2 2026 print before the open Wednesday, with elevated expectations from prior Q1 growth and guidance, offset by facility-delay risk highlighted by DA Davidson.

02

Market read

This is a single-name catalyst story with a peer earnings spillover, plus macro CPI/PPI risk that could affect growth-tech sentiment.

03

What to watch

Vineland facility completion timing and any changes to capital spending plans could be the key swing factor versus the bullish supply/pricing narrative.

Relevance 7/10Novelty 5/10Timing: into Nebius Q2 results before the market open Wednesday

Background

The article frames today’s move as driven by a Goldman bullish pre-earnings note for Nebius, plus expectations for CoreWeave’s Q2 report after the close.

Company-level read

Ticker impact

$NBISBullishMedium confidence
Context

Nebius shares rose 5.4% after Goldman issued a bullish pre-earnings note, citing strong AI infrastructure setup and a street-high price target.

Expected impact

Shares may stay bid into the Q2 open, with volatility around any mismatch between expectations and Q2 results.

Evidence & confidence

The article attributes the move to a same-day bullish note and a separate bearish price-target cut, plus upcoming Q2 timing and facility-delay risk.

Market effects

Sympathy buying in neocloud/AI data-center infrastructure names ahead of peer earnings (CoreWeave), reinforcing momentum trades.

No specific regional driver beyond US CPI/PPI risk appetite for growth tech.

AI data-center demand expectations remain a global theme, but the catalyst described is company- and peer-specific.

Counterpoint

The rally may be largely positioning around analyst notes and peer earnings, while facility delays and capex discipline concerns could cap upside if Q2 disappoints.

Key entities

  • Nebius Group NV

    AI infrastructure provider whose stock is up on a bullish pre-earnings note and ahead of its Q2 results.

  • CoreWeave

    AI data-center/compute peer scheduled to report Q2 earnings after the market close, driving sympathy buying.

  • Goldman Sachs

    Published a bullish pre-earnings note with a street-high price target for Nebius.

  • DA Davidson

    Cut its Nebius price target to $175 from $250 while keeping a Neutral rating, citing Vineland facility delays.

Related articles

$NBISMed

With a $40 Billion Backlog, Nebius Stock Appears Positioned for Sustained Growth

Nebius reported Q4 FY25 revenue up 547% YoY and guided Q1 FY26 revenue growth of 684%. For FY26, it expects revenue of $3.0B to $3.4B and ARR of $7B to $9B, with adjusted EBITDA guidance of 40%. The company said it ended Q1 with $9.3B cash and has $40B contracted revenue from customers including Microsoft and Meta. Analysts rate NBIS “Moderate Buy” with a $252.07 mean target.

$NBISMedAI 8/10

CoreWeave’s Record Q2 Supercharges Nebius Stock Ahead Of Earnings — What Does Wall Street Expect Amid Cloud Boom?

CoreWeave reported record Q2 results, with revenue up 112% to $2.58B and adjusted loss per share of $1.03, beating estimates, and raised 2026 guidance to $12.4B-$13.2B revenue and $35B-$39B capex. Nebius (NBIS) shares rose about 7% ahead of its Q2 report, with analysts expecting revenue up 446% to $574.6M and a $0.70 adjusted loss per share.

$NBISMed

Nebius Group NBIS Rallies As $1B AI Deal Fuels Volatility

Nebius Group N.V. (NBIS) rose in premarket after announcing a multi-year deal to sell more than $1B of computing power to Reflection AI through 2029, according to the report. The article cites NBIS as an AI-cloud data center operator and notes volatility tied to AI infrastructure and New York hyperscale moratorium news.

$CRWVHighAI 8/10

After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB

After-hours trading saw gains in CoreWeave (CRWV) after a smaller-than-expected Q2 loss of $1.14 per share on $2.58B revenue and a $104B backlog plus $25B+ Q3 commitments. Super Micro (SMCI) rose on Q4 results and Q1 FY2027 revenue guidance $14.5B-$15.5B. CAVA, LITE, and HRB also moved on quarterly beats and outlooks.

$NBISMed

Nebius Is Rising While Oracle Falls: NVIDIA’s Massive $500 Billion Funding Plan Pushes the Stocks in Opposite Directions

Nebius Group (NBIS) rose about 3.7% to around $191 midday Tuesday while Oracle (ORCL) fell about 3.9% to about $145. The move followed reports that NVIDIA (NVDA) is pushing a roughly $500 billion “neocloud” AI infrastructure funding plan, including a $2 billion pre-funded warrant for Nebius. Nebius reported Q2 AI Cloud segment growth of 841% and has an average analyst price target near $250.75.

$NBISMed

DA Davidson cuts Nebius target 30% as Vineland delays threaten 2026 guidance

DA Davidson cut its Nebius Group (NBIS) price target to $175 from $250 and kept a Neutral rating, citing construction delays at Nebius’ Vineland, New Jersey data-center project. The firm said Vineland may not be completed in 2026, potentially weakening Nebius’ 2026 guidance. Nebius previously said it was on track to deliver capacity to Microsoft.